Epigenetic regulation of SMARCB1 By miR‐206, ‐381 and ‐671‐5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR‐765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas
- 25 May 2016
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 55 (10), 786-802
- https://doi.org/10.1002/gcc.22379
Abstract
Complete/partial loss of SMARCB1 nuclear-immunopositivity is characteristic of a certain subset of soft tissue sarcomas (STSs). Our previous work showed that oncomiRs-206,-381, and 671-5p could silence the SMARCB1 mRNA and protein expression and that they display significant overexpression in epithelioid sarcomas (ESs). MiR-765 was overexpressed too, but functionally was inactive in the silencing. In the current work, using quantitative PCR, we conducted a miRNA study of 51 ESs, 20 rhabdoid tumors (RTs), 20 synovial sarcomas (SSs), 15 malignant peripheral nerve sheath tumors (MPNSTs), 11 myoepithelial carcinomas (MECs), and 10 extraskeletal myxoid chondrosarcomas (EMCSs) with complete/partial loss of SMARCB1 nuclear immunostain, in contrast to controls (SMARCB1-immunopositive) of 96 STSs, 13 melanomas and 10 sarcomatoid carcinomas. The SMARCB1 genetic status of ESs was determined by MLPA and FISH. A subset of ESs (5/51) showed biallelic deletion of SMARCB1 with no overexpression of any miRNA, suggesting these tumors could be the counterpart of pediatric RT, at least genetically. Another subset (5/51) was genetically either intact or monoallelic deleted with at least threefold overexpression of one of miR-206,-381,-671-5p, suggesting epigenetic regulation only. 39/51 ESs had a biallelic deletion (>20% by FISH and/or by MLPA) but with overexpressed miR-206,-381, and 671-5p, suggesting intratumoral heterogeneity, i.e., both genetic and epigenetic regulation. At least threefold overexpression of one of miR-206,-381, and 671-5p was detected in all MPNSTs, EMCSs, SSs and 7 MCs. Except for ESs, four SSs and one MPNST, there was no event above threefold overexpression of miR-765 among all 195 tested tumors. Our results suggest a general role of miR-206,-381, and 671-5p in SMARCB1 gene silencing of ES, MC, EMCS, MPNST and SS. In the future, miR-765 could possibly be a diagnostic tool for ES because of its 97% specificity and 80% sensitivity.Funding Information
- Országos Tudományos Kutatási Alapprogramok
This publication has 39 references indexed in Scilit:
- Explosive beginningsNature Reviews Cancer, 2015
- The Expanding Family of SMARCB1(INI1)-deficient NeoplasiaAdvances in Anatomic Pathology, 2014
- miR‐16 inhibits cell proliferation by targeting IGF1R and the Raf1–MEK1/2–ERK1/2 pathway in osteosarcomaFEBS Letters, 2013
- Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumorExperimental Cell Research, 2012
- TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcomaBiochemical and Biophysical Research Communications, 2012
- EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 geneGenes, Chromosomes and Cancer, 2010
- Epithelioid SarcomaAmerican Journal of Clinical Pathology, 2009
- RhoA-Dependent Regulation of Cell Migration by the Tumor Suppressor hSNF5/INI1Cancer Research, 2008
- Epithelioid sarcoma in children and adolescentsCancer, 2005
- Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancersProceedings of the National Academy of Sciences of the United States of America, 2004